Picking up the Clues Bert the breathless patient….. March 2015 GL/XBR/0315/0356.

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

ABCDABCD mMRC < 2 CAT 2 CAT > >2>2 RISK GOLD RISK Exacerbation TypeCharatteristicSpirometric classification Exacerbation Per.
End of life research in COPD
Exercise and Pulmonary Rehabilitation
Clinical Knowledge Summaries CKS Chronic obstructive pulmonary disease (COPD) Diagnosis of COPD in primary care Educational slides based on the CKS topic.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Chronic obstructive pulmonary disease (COPD) Professor Bill MacNee
Deep breath and blow - the HCA role in respiratory care
© 2013 Global Initiative for Chronic Obstructive Lung Disease
1 PULMONARY REHABILITATION Asthma/COPD Study Day 11/12/13 Fran Butler Respiratory Physiotherapist.
COPD AS Systemic disease BY Dr/Sami EL-Dahdouh (MD) Lecturer of Pulmonary & Critical care Faculty of Medicine, Menofia University.
Medicines optimisation can help reduce COPD related hospital admissions and exacerbations - LCH MMT Approach Alison McMinn Respiratory Lead Pharmacist.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Out of Breath? Know When to See a Physician
Pulmonary-Allergy Drugs Advisory Committee September 6, SGRQSGRQ 3 Domains: –Symptoms: cough, sputum production, wheeze, breathlessness, duration.
Home Care of Chronic Obstructive Pulmonary Disease Patients.
Breathless Patient Aaqid Akram MBChB (2013) Clinical Education Fellow.
Severe breathlessness
Improving the experience of all Londoners with COPD and minimising the impact of the disease London Respiratory Team Primary Care Intelligence A GP Perspective.
Picking up the Clues Bert the breathless patient….. Date of Preparation: Mar 2015 GL/XBR/0315/0356.
내과 R2 이지훈 N Engl J Med Sep 8.
Definition Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation and a range of pathological changes in the lung.
Management of stable chronic obstructive pulmonary disease (2) Seminar Training Primary Care Asthma + COPD D.Anan Esmail.
PULMONARY REHABILITATION.
Development of disability in chronic obstructive pulmonary disease : beyond lung function MarkDEisner, CarlosIribarren, PaulDBlanc, EdwardHYelin, LynnAckerson,
Quantification of dyspnea using descriptors: Development and initial testing of the Dyspnea-12 J Yorke, S H Moosavi, C Shuldham, P W Jones (Thorax
Clinical Knowledge Summaries CKS Chronic obstructive pulmonary disease (COPD) Diagnosis of COPD in primary care Educational slides based on the CKS topic.
GOLD 2017 major revision: Summary of key changes
Heni Retnowulan, dr., SpPD-KP
Why anxiety associates with non-completion of pulmonary rehabilitation program in patients with COPD? Dr Abebaw Mengistu Yohannes Associate Professor.
The Minimal Important Difference for St
S Lungaro-Mifsud, S Montefort
COPD Report 5 Coles Lane, Oakington, Cambridge, CB24 3BA.
Session 9: Management of COPD
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
Reduced Quality of Life
Kyrgyz State Medical Academy
The Role of Fixed-Dose Dual Bronchodilator Therapy in Treating COPD
REMOTE PULMONARY REHABILITATION A Model for Delivery
Bar charts comparing the results of ePROMs between patients who found the scores inadequately assessed their symptoms against all other patients leaving.
Disease progression is preceded by right ventricular remodelling, but not by changes in clinical parameters. Disease progression is preceded by right ventricular.
Symptoms measured by Edmonton Symptom Assessment Scale according to modified Medical Research Council (mMRC) dyspnoea scale groups. Symptoms measured by.
Studies have shown that classical efficacy RCTs exclude about 90% for a) asthma and 95% for b) COPD routine care populations due to strict inclusion and.
Level of physical activity by Global Initiative for Obstructive Lung Disease (GOLD) stage, BODE (body mass index, FEV1 for airflow obstruction, dyspnoea,
Occurrence of morning symptoms
Diagnosi della BPCO 1.
Representative diaphragm electromyogram (EMG) tracings at rest (a and b) and during maximum voluntary ventilation (c and d) in a healthy subject (a and.
Management of Chronic Stable COPD
Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.
A–f) Respiratory mechanical measurements during incremental cycle exercise in patients with moderate chronic obstructive pulmonary disease (COPD) and age-matched.
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
A family-based pulmonary rehabilitation (PR) programme enhanced the coping resources of the families of chronic obstructive pulmonary disease patients.
Effects of chronic obstructive pulmonary disease (COPD) severity on different parameters of ventilatory inefficiency during incremental cardiopulmonary.
Exertional dyspnoea intensity is shown relative to a) work rate and b) diaphragm electromyography relative to maximum (EMGdi/EMGdi,max) during incremental.
E. Rand Sutherland, MD, MPH  Journal of Allergy and Clinical Immunology 
Decline of lung function of a LTX patient who rapidly developed severe BOS at our centre. Decline of lung function of a LTX patient who rapidly developed.
A) Exertional dyspnoea and b) leg discomfort intensity (Borg score) are shown in response to increasing minute ventilation (V′E) and/or work rate during.
And WHY does it matter which label?
Plots showing baseline correlation between the modified Medical Research Council (mMRC) dyspnoea scale, Baseline Dyspnoea Index (BDI), COPD Assessment.
Correlation between inspiratory capacity (IC)/total lung capacity (TLC) ratio and oxygen pulse at peak exercise in chronic obstructive pulmonary disease.
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification based on symptom and risk evaluation. a) GOLD model of symptom/risk evaluation.
Progression in the patient’s pulmonary function tests from 2010 to a) Forced vital capacity (FVC); b) total lung capacity (TLC); c) diffusing capacity.
Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting 
Scatterplots showing baseline correlation between forced expiratory volume in 1 s (FEV1) % pred and a) COPD Assessment Test (CAT), b) Clinical COPD Questionnaire.
A) Operating lung volumes and b) breathing frequency (Fb) during incremental cycle exercise in patients with moderate chronic obstructive pulmonary disease.
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Interventional bronchoscopic and surgical treatments.
A) Dyspnoea response at rest, iso-time, and peak exercise in 20 patients with fibrotic interstitial lung disease during constant work-rate cycle exercise.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD scheme for classifying patients with COPD with separate appraisal of air-flow limitation.
Frequency distribution histograms of the Exacerbations of Chronic Pulmonary Disease Tool (EXACT) total, the COPD Assessment Test (CAT), the St George’s.
Change in COPD (chronic obstructive pulmonary disease) assessment test (CAT) score after pulmonary rehabilitation corresponding to different responses.
Presentation transcript:

Picking up the Clues Bert the breathless patient….. March 2015 GL/XBR/0315/0356

Other causes of breathlessness

Reproduced with permission from Dr Noel Baxter GP

How do we assess breathlessness and impact on the life of someone living with COPD?

MRC Dyspnoea Score GradeDegree of breathlessness related to activities 1Not troubled by breathlessness except on strenuous exercise 2Short of breath when hurrying or walking up a slight hill 3 Walks slower than contemporaries on level because of breathlessness, or stops for breath when walking at own pace 4Stops for breath after walking about 100m or a few minutes on the level 5Too breathless to leave the house, or breathless when dressing or undressing Fletcher CM (Chairman) (1960). Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the aetiology of chronic bronchitis (MRC Breathlessness Score) British Medical Journal 2, 1665

Modified MRC (mMRC)

Other tools to consider Visual analogue scales Oxygen cost diagram Noseda A, Carpiaux JP, Schmerber J, Yernault J-C (1992). Dyspnoea assessed by visual analogue scale in patients with obstructive lung disease during progressive and high intensity exercise. Thorax 47; McGavin CR, Artvinli M, Naoe H, McHardy GJR (1978). Dyspnoea, disability and distance walked: comparison of estimates of exercise performance in respiratory disease. British Medical Journal 2;

Assessing response Able to do more? Less breathless? Able walk further? Feels better? Sleeps better? Jones PW, Harding G, Berry P, et al (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal. 34:

COPD Assessment Test (CAT) Validated tool Assess impact on health status Different domains Composite score but need to look at individual domain scores Jones PW, Harding G, Berry P, et al (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal. 34:

What other tools are out there? Research or real life?

Treatment choices in COPD Bronchodilators are the mainstay of treatment for COPD Even if reversibility tests are negative patients can be less breathless and feel better.

Bronchodilators FEV 1 RV FEV 1 RV Total lung capacity FVC Pre-bronchodilator Post-bronchodilator Booker R, 2006 ©Education for Health.

Why use bronchodilators? The optimal drug and dose needs to be determined individually after therapeutic trial Measure response by improvements in disability and ‘well-being’.

Reproduced with permission from Dr Noel Baxter GP